DK0917471T3 - Behandling og diagnose af grampositive kokinfektioner - Google Patents

Behandling og diagnose af grampositive kokinfektioner

Info

Publication number: DK0917471T3
Authority: DK; Denmark
Prior art keywords: diagnosis; methods; treatment; same; gram
Prior art date: 1996-07-06

Application number

DK97930642T

Other languages

English (en)

Inventor

James Peter Burnie

Ruth Christine Matthews

Original Assignee

Neutec Pharma Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-06

Filing date

1997-07-07

Publication date

2005-06-06

1997-07-07 Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc

2005-06-06 Application granted granted Critical

2005-06-06 Publication of DK0917471T3 publication Critical patent/DK0917471T3/da

Links

238000003745 diagnosis Methods 0.000 title abstract 3
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 title 2
229960003920 cocaine Drugs 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
238000000034 method Methods 0.000 abstract 4
239000011230 binding agent Substances 0.000 abstract 2
239000012634 fragment Substances 0.000 abstract 2
230000002163 immunogen Effects 0.000 abstract 2
230000003472 neutralizing effect Effects 0.000 abstract 2
108010006533 ATP-Binding Cassette Transporters Proteins 0.000 abstract 1
102000005416 ATP-Binding Cassette Transporters Human genes 0.000 abstract 1
241000295644 Staphylococcaceae Species 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000002405 diagnostic procedure Methods 0.000 abstract 1
230000002538 fungal effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cephalosporin Compounds (AREA)

DK97930642T 1996-07-06 1997-07-07 Behandling og diagnose af grampositive kokinfektioner DK0917471T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9614274.0A GB9614274D0 (en)	1996-07-06	1996-07-06	Treatment and diagnosis of infections of gram positive cocci
PCT/GB1997/001830 WO1998001154A2 (en)	1996-07-06	1997-07-07	Treatment and diagnosis of infections of gram positive cocci

Publications (1)

Publication Number	Publication Date
DK0917471T3 true DK0917471T3 (da)	2005-06-06

Family

ID=10796521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97930642T DK0917471T3 (da)	1996-07-06	1997-07-07	Behandling og diagnose af grampositive kokinfektioner

Country Status (13)

Country	Link
US (2)	US6544516B1 (da)
EP (1)	EP0917471B1 (da)
JP (1)	JP2001505534A (da)
AT (1)	ATE293456T1 (da)
AU (1)	AU717332B2 (da)
CA (1)	CA2259141C (da)
DE (1)	DE69733067T2 (da)
DK (1)	DK0917471T3 (da)
ES (1)	ES2238080T3 (da)
GB (1)	GB9614274D0 (da)
NZ (1)	NZ332991A (da)
PT (1)	PT917471E (da)
WO (1)	WO1998001154A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6610293B1 (en) *	1997-06-16	2003-08-26	The Henry M. Jackson Foundation For The Advancement Of Military Medicine	Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
GB9806762D0 (en) *	1998-03-31	1998-05-27	Neutec Pharma Plc	Treatment and diagnosis of staphylococcal infections
EP1624064A3 (en) *	1998-07-27	2006-05-10	Microbial Technics Limited	Nucleic acids and proteins from streptococcus pneumoniae
WO2002057406A2 (en) *	2001-01-17	2002-07-25	Avestha Gengraine Technologies Pvt Ltd	Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops
CA2446294A1 (en) *	2001-05-08	2002-11-14	Yi Xu	Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
GB0127983D0 (en) *	2001-11-22	2002-01-16	Neutec Pharma Plc	Treatment of micro-organism infection
US8729013B2 (en)	2004-08-26	2014-05-20	The University Of Western Ontario	Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
EP2450053B1 (en) *	2010-11-05	2016-06-15	Universitätsklinikum Freiburg	Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
EP2872535A1 (en)	2012-07-16	2015-05-20	Pfizer Inc.	Saccharides and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5747239A (en) *	1990-02-16	1998-05-05	United Biomedical, Inc.	Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
WO1993006247A1 (en) *	1991-09-16	1993-04-01	Abbott Laboratories	Hepatitis c assay
GB9401689D0 (en)	1994-01-28	1994-03-23	Univ Manchester	Diagnosis and treatment of endocarditis

1996
- 1996-07-06 GB GBGB9614274.0A patent/GB9614274D0/en active Pending
1997
- 1997-07-07 EP EP97930642A patent/EP0917471B1/en not_active Expired - Lifetime
- 1997-07-07 AU AU34522/97A patent/AU717332B2/en not_active Ceased
- 1997-07-07 NZ NZ332991A patent/NZ332991A/xx not_active IP Right Cessation
- 1997-07-07 DK DK97930642T patent/DK0917471T3/da active
- 1997-07-07 US US09/214,307 patent/US6544516B1/en not_active Expired - Fee Related
- 1997-07-07 AT AT97930642T patent/ATE293456T1/de not_active IP Right Cessation
- 1997-07-07 PT PT97930642T patent/PT917471E/pt unknown
- 1997-07-07 JP JP50494298A patent/JP2001505534A/ja not_active Ceased
- 1997-07-07 ES ES97930642T patent/ES2238080T3/es not_active Expired - Lifetime
- 1997-07-07 WO PCT/GB1997/001830 patent/WO1998001154A2/en not_active Ceased
- 1997-07-07 DE DE69733067T patent/DE69733067T2/de not_active Expired - Lifetime
- 1997-07-07 CA CA002259141A patent/CA2259141C/en not_active Expired - Fee Related
2002
- 2002-01-25 US US10/054,968 patent/US6881410B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO1998001154A2 (en)	1998-01-15
GB9614274D0 (en)	1996-09-04
US6881410B2 (en)	2005-04-19
WO1998001154A3 (en)	1998-06-25
JP2001505534A (ja)	2001-04-24
AU3452297A (en)	1998-02-02
ATE293456T1 (de)	2005-05-15
DE69733067D1 (de)	2005-05-25
PT917471E (pt)	2005-07-29
AU717332B2 (en)	2000-03-23
US20030119101A1 (en)	2003-06-26
EP0917471B1 (en)	2005-04-20
NZ332991A (en)	1999-06-29
CA2259141C (en)	2007-12-11
US6544516B1 (en)	2003-04-08
DE69733067T2 (de)	2006-01-26
ES2238080T3 (es)	2005-08-16
CA2259141A1 (en)	1998-01-15
EP0917471A2 (en)	1999-05-26

Publication	Publication Date	Title
TR200102497T2 (tr)	2002-01-21	Yeni streptococcus antijenleri
DE60044058D1 (de)	2010-05-06	Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
NO20012812L (no)	2001-08-02	Vaksinesammensetning og vaksine samt anvendelse av polypeptid og polynukletid
NO973447L (no)	1997-09-26	Monoklonale antistoffer som er spesifikke for forskjellige epitoper i human-gp 39, og fremgangsmåter for deres anvendelse i diagnose og terapi
EP1757697A3 (en)	2007-05-30	Group B streptococcus antigens
UY26783A1 (es)	2002-01-31	Antígenos de estreptococo.
WO1998042740A3 (en)	1999-01-07	Compounds and methods for the diagnosis and treatment of ehrlichia infection
NO20030252D0 (no)	2003-01-17	Forbindelser og fremgangsmåter for behandling og diagnostikk av klamydiainfeksjon
WO1998008542A3 (en)	1998-07-09	Compounds and methods for treatment and diagnosis of mycobacterial infections
PT917471E (pt)	2005-07-29	Tratamento e diagnostico de infeccoes por cocci gram-positivo
ATE310088T1 (de)	2005-12-15	Behandlung und nachweis von staphylokokkeninfektionen
GB2278357B (en)	1997-03-05	Humanised antibodies directed against A33 antigen
DE69714451D1 (de)	2002-09-05	Prionbindende proteine und deren verwendungen
WO2004003155A3 (en)	2004-06-17	Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
WO2001085949A3 (en)	2002-06-27	Compounds and methods for the diagnosis and treatment of ehrlichia infection
IL159479A (en)	2010-12-30	Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
GB9810084D0 (en)	1998-07-08	Proteins
AU3637195A (en)	1996-04-09	Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
PT998493E (pt)	2005-03-31	Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
EP1950302A3 (en)	2010-06-23	Streptococcus antigens
MX9800191A (es)	1998-05-31	Peptidos novedosos derivados de proteina humana 60 producida por choque termico, para tratamiento de diabetes, composiciones, metodos y equipos.